Health Trials

About this trial

The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.

Eligibility criteria

Qualifiers

Women with indication for elective caesarean section.

Age less than 35 years old.

Gestational age less than 38 weeks.

Gestational age will be confirmed by certain LMP or reliable early ultrasound measurement of crown-rump length.

Disqualifiers

Any obstetric disorders as preeclampsia and diabetes.

Fetus with oligohydramnios, intrauterine growth restriction.

Any contraindications to misoprostol like those with previous allergic reaction or hypersensitivity to prostaglandin hemorrhagic disorders, and severe anemia.

History of more than or equal 2 previous caesarean section.

Trial design

Treatments tested in this trial

  • Misoprostol

Treatment groups

160 Participants
are divided into 2 treatment groups

Locations

1
Kafr El-sheikh University Hospital Kafr Ash Shaykh, Egypt Egypt

Sponsors and collaborators

Kafrelsheikh University

Lead sponsor

Source ClinicalTrials.gov